0001209191-18-049414.txt : 20180904
0001209191-18-049414.hdr.sgml : 20180904
20180904214526
ACCESSION NUMBER: 0001209191-18-049414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180830
FILED AS OF DATE: 20180904
DATE AS OF CHANGE: 20180904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Last Andrew J.
CENTRAL INDEX KEY: 0001485088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 181053786
MAIL ADDRESS:
STREET 1: 3420 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-775-0515
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-30
0
0001642380
OncoCyte Corp
OCX
0001485088
Last Andrew J.
20374 SENECA MEADOWS PARKWAY
GERMANTOWN
MD
20876
1
0
0
0
Common Stock, no par value
6993
D
Option to Purchase Common Stock
2.40
2018-08-30
4
A
0
45000
0.00
A
2028-08-29
Common Stock
45000
45000
D
Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
/s/Andrew J. Last
2018-09-04